Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04267705 · ClinicalTrials.gov registry record · NA
Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human
A NA study of Overweight or Obesity and Insulin Sensitivity, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- Active
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 1
- Study location
NCT04267705: Active NA study of Overweight or Obesity and Insulin Sensitivity, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
NCT04267705 is a NA study of Overweight or Obesity and Insulin Sensitivity that is active but no longer recruiting, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 103 participants, below the 31,709-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04267705, a NA study of Overweight or Obesity and Insulin Sensitivity, is active but no longer recruiting, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 1
- Study location
Study Summary
Objective 1: Characterize indices of systemic inflammation and gut microbiota composition and function after chronic (12 weeks) intake of pulses compared to control diet in human OW/OB-IR participants. Objective 2: Characterize dietary- and microbial-derived metabolite pools after regular intake of pulses (12 weeks) in human participants with OW/OB-IR compared to control diet. Objective 3: Characterize cognitive functioning after chronic (12 weeks) intake of pulses compared to control diet in human OW/OB-IR participants.
Primary Outcome
Investigate Nrf2/ NF-κB activation in PBMC
Conditions Studied
Interventions
- OTHER Control
- OTHER Black bean
- OTHER Chickpea
Study Locations (1)
Illinois
- Clinical Nutrition Research Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2026-01-30 |
| Phase | NA |
What the registry record for NCT04267705 still lists
NCT04267705 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 31,709-participant average among 32 other Overweight or Obesity trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Overweight or Obesity appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT04267705 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04267705 about?
NCT04267705 is a clinical study titled "Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human". Objective 1: Characterize indices of systemic inflammation and gut microbiota composition and function after chronic (12 weeks) intake of pulses compared to control diet in human OW/OB-IR participants. Objective 2: Characterize dietary- and microbial-derived metabolite pools after regular intake of...
What is the current status of trial NCT04267705?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 103 participants. The study started on 2020-02-24. Estimated completion is 2026-01-30.
What conditions does trial NCT04267705 study?
This clinical trial studies the following conditions: Overweight or Obesity, Insulin Sensitivity, Inflammatory Response.
What interventions are being tested in trial NCT04267705?
The interventions under investigation include: Control (OTHER), Black bean (OTHER), Chickpea (OTHER).
Who is sponsoring clinical trial NCT04267705?
This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04267705 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight or Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04267705's enrollment target sits among peer trials
103 24th of 32 higher than 9 of 32 other Overweight or Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight or Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women
RECRUITING · NA
-
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
RECRUITING · NA
-
Craving Network Neurofeedback
RECRUITING · NA
-
Postprandial Effects of Animal Versus Plant-Based Protein
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI